Not much movement in sight sciences results.
- down 9% on PCP
- up 11% on least qtr
interesting bits are
1) summary of proposed fees changes which will benefit us also
2) they have a 5% increase in ordering accounts and talk about growth in the sector overall, which given their existing large base of glaucoma surgeons could indicate move cataract surgeons moving to combined surgery which is a trend that would also benefit us
their current qtrly revenue is so large compared to us it’s not yet possible to see what’s qtrly fluctuations versus market share erosions due to our superior device. This will become muchmore obvious in the next 6/12/18 months
https://investors.sightsciences.com/news-releases/news-release-details/sight-sciences-reports-second-quarter-2024-financial-results-and
- Forums
- ASX - By Stock
- EYE
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-239
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.48M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 0.230 |
2 | 102500 | 0.225 |
3 | 47271 | 0.220 |
2 | 128966 | 0.215 |
9 | 273945 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 2000 | 1 |
0.230 | 3 | 1 |
0.235 | 337606 | 1 |
0.240 | 11666 | 1 |
0.245 | 6000 | 1 |
Last trade - 09.22am 02/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
Day chart unavailable